Related Experiment Video
Updated: Aug 12, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Anticardiolipin antibodies and the severity of preeclampsia-eclampsia
E Martínez-Abundis1, M González-Ortiz, V Cortés-Llamas
1Clinical Epidemiology Research Unit and Hospital of Obstetrics and Gynecology, Western Medical Center, Mexican Institute of Social Security, and Physiology Department, Health Science Center, University of Guadalajara, Guadalajara City, Mexico.
Objective:
To identify and compare anticardiolipin antibodies (aCL) in patients with eclampsia, different grades of preeclampsia and women with normotensive pregnancy.
Methods:
A cross-sectional study was conducted in 13 patients with eclampsia, 39 with preeclampsia (13 severe, 26 mild), and 52 normotensive pregnant women. All of them were studied in the 3rd trimester of pregnancy. The aCL were determined by an ELISA method.
Results:
There were no significant differences in IgG aCL (F = 0.33, p = 0.80) and IgM aCL (F = 1.64, p = 0.18) between patients with eclampsia (6.9 +/- 3.9 U/GPL and 4.0 +/- 2.0 U/MPL), severe preeclampsia (5.7 +/- 3.5 U/GPL and 2.9 +/- 1. 3 U/MPL), mild preeclampsia (6.8 +/- 3.9 U/GPL and 2.8 +/- 1.0 U/MPL) and normotensive pregnant women (6.4 +/- 3.4 U/GPL and 3.0 +/- 1.8 U/MPL). None of the values of the aCL were considered as positive.
Conclusion:
Serum aCL levels were similar in patients with different grades of preeclampsia-eclampsia and women with normotensive pregnancy.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Pericarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Hypertension III: Clinical Manifestations and Diagnostic Studies
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

